GlassScriptPhysician profile
Samantha J Ferris
NPI 1528330347
$1,422.67
in general payments reported to CMS, 2019-2025
13 companies · $609 in 2025
The $609 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $583 · 2024: $231 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $615.57 | 2023-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Viiv Healthcare Company | $190.26 | 2023-2025 | Rukobia, Cabenuva, Apretude |
| Boston Scientific Corporation | $135.77 | 2023 | Watchman Flx |
| Abbvie INC. | $113.76 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $106.78 | 2023-2025 | Abilify Asimtufii, Abilify Maintena |
| Cvrx, INC. | $78.69 | 2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $46.48 | 2025 | Assure Wcd |
| Janssen Biotech, INC. | $33.16 | 2023 | Symtuza |
| Organogenesis INC. | $27.18 | 2024 | |
| Theratechnologies INC. | $22.73 | 2024 | Egrifta Sv |
| Halozyme INC | $18.25 | 2023 | |
| Indivior INC. | $17.08 | 2023 | Perseris |
| Janssen Pharmaceuticals, INC | $16.96 | 2024 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Ferris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.